Overview
Large Language Models (LLMs) in healthcare apply transformer-architecture AI models — either general-purpose foundation models (GPT, Claude, Gemini) or clinically-fine-tuned variants (Med-PaLM 2, GatorTron, ClinicalBERT derivatives) — to healthcare tasks. LLMs' ability to understand and generate fluent clinical narrative has transformed several RCM and clinical workflows since 2023, with adoption accelerating continuously.
Use cases span clinical documentation (ambient scribes, note summarization, note drafting), coding (autonomous coding, CAC, CAPD), prior authorization (documentation completion, medical-necessity summarization), patient-facing applications (symptom triage, appointment scheduling, post-visit summaries), back-office operations (denial letter analysis, appeal drafting), clinical decision support (guideline summarization, differential diagnosis support), and research (literature review, cohort identification).
Accuracy varies substantially by task type. Structured-output tasks (extraction, classification, coding) typically achieve 85–95% accuracy with well-tuned models. Open-ended generation tasks (note drafting, clinical reasoning) are variable — impressive fluency but risk of hallucination, missed nuance, and oversimplification. Clinical governance frameworks must distinguish high-confidence task types where LLMs can operate autonomously from judgment-requiring tasks where LLMs augment but do not replace clinical professionals.
Hallucination risk is the central LLM-specific concern in clinical use. LLMs can generate plausible-sounding but factually incorrect content — invented medications, imagined lab values, fabricated diagnoses. Mitigation strategies include retrieval-augmented generation (grounding LLM outputs in retrieved source data), confidence scoring, structured-output constraints, expert review of generated content before action, and ongoing accuracy monitoring.
Bias and equity concerns require attention. LLMs trained on historical medical literature and clinical notes inherit biases present in that training data — underrepresentation of certain patient populations, biased clinical-decision patterns, inequitable guideline application. Healthcare-LLM governance must include equity assessment, bias testing on representative patient populations, and ongoing monitoring for disparate impact.
Privacy and PHI concerns are substantial. LLMs typically should not be trained on PHI without appropriate governance and data-protection controls; LLMs used in production with patient data require HIPAA-compliant infrastructure (BAA execution, private-deployment or appropriately-configured API access, audit logging). Many healthcare LLM deployments use private cloud deployments rather than public API access to maintain PHI control.
For RCM leaders, LLM governance includes vendor assessment, use-case approval, accuracy benchmarking, clinical-governance-committee oversight, and ongoing monitoring. The pace of LLM capability improvement requires continuous governance attention; what was infeasible in 2023 became routine by 2025. Organizations that invest in governance infrastructure to evaluate and deploy LLMs responsibly tend to capture the benefits; organizations without governance frameworks either miss adoption opportunities or deploy with inadequate controls.
From a coding-compliance standpoint, Large Language Models in Healthcare lives at the intersection of CPT-category specificity, payer-specific guidance, and internal documentation standards. Practices that run a quarterly Large Language Models in Healthcare audit against nlp healthcare and autonomous coding consistently close the coder-provider feedback loop faster than practices that wait for the annual OIG or payer audit to surface the pattern. Reviewers on this site flag Large Language Models in Healthcare entries whenever payer guidance shifts materially so the associated claim-scrubber logic is updated before the next billing cycle.
Industry benchmark
Foundation model performance: GPT-4/Claude 3.5/Gemini 1.5 class models pass US Medical Licensing Exam questions and match many specialist benchmarks. Clinical-specific fine-tuning: incremental improvement on specialized tasks. Production deployment: rapidly expanding across RCM and clinical use cases.
Worked example
A health system deploys a HIPAA-compliant LLM for denial-letter analysis. The LLM reads incoming denial letters, extracts denial reasons and required documentation, and drafts appeal letters. Denial-management staff review and send appeals with roughly 30% time reduction per appeal. Appeal-success rates remain equivalent to manual workflow.
Frequently asked questions — Large Language Models in Healthcare
Are LLMs safe for clinical use?
Safety depends on task, implementation, and governance. Structured-output tasks with validation are relatively safe; open-ended clinical-reasoning tasks without expert review carry substantial risk. Careful governance is essential.
Do healthcare LLMs need to be clinically fine-tuned?
Not always — strong general-purpose models perform well on many tasks. Clinical fine-tuning improves domain-specific accuracy and reduces hallucinations. Trade-off: fine-tuning requires resources; vendor-supplied general-purpose models with good prompting often suffice.
Can LLMs replace clinicians?
No — LLMs augment clinicians. Task automation (documentation, coding, summarization) scales clinical expertise; autonomous clinical decision-making requires human judgment, patient relationship, and accountability that LLMs do not provide.
Disclaimer
This glossary entry is operational reference for revenue-cycle and medical-billing professionals. It is not legal, clinical, or contractual advice. Industry benchmarks cite named public sources where available; always verify against the current guidance from the authority body before relying on a number in a contract, policy, or compliance filing.